Form D · Pharmaceuticals
PIPER THERAPEUTICS INC.
Cambridge, MA · CIK 0001654487
Offering snapshot reported May 19, 2016 · SEC filing
- Reported sold
- $1.3M Offering amount: $1.3M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 6, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 19, 2016 | Initial | $1,295,013 | No comparison | 5 | SEC filing |
| Oct 1, 2015 | Initial | $200,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-263541
Series Seed Preferred Stock
Source: Form D, filed May 19, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Lim | Director |
| Lois Smith | Executive |
| Russell J. Wilcox | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
One Broadway, 14 Th Fl
Cambridge, MA, 02142
Cambridge, MA, 02142